P

PCC Rokita SA
WSE:PCR

Watchlist Manager
PCC Rokita SA
WSE:PCR
Watchlist
Price: 73.1 PLN 1.67% Market Closed
Market Cap: 1.5B PLN
Have any thoughts about
PCC Rokita SA?
Write Note
Section:
 
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

PCR Price Targets Summary
PCC Rokita SA

Wall Street analysts forecast PCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCR is 86.68 PLN with a low forecast of 83.4 PLN and a high forecast of 91.77 PLN.

PCR Lowest Forecast
Wall Street Target
83.4 PLN
14% Upside
PCR Average Forecast
Wall Street Target
86.68 PLN
19% Upside
PCR Highest Forecast
Wall Street Target
91.77 PLN
26% Upside
Lowest
Price Target
83.4 PLN
14% Upside
Average
Price Target
86.68 PLN
19% Upside
Highest
Price Target
91.77 PLN
26% Upside
PCC Rokita SA Competitors:
Price Targets
ASH
Ashland Global Holdings Inc
26% Upside
DD
Dupont De Nemours Inc
20% Upside
BCPC
Balchem Corp
6% Upside
UZU
Uzin Utz AG
32% Upside
ASH
Ashland Global Holdings Inc
26% Upside
DD
Dupont De Nemours Inc
20% Upside
BCPC
Balchem Corp
6% Upside
UZU
Uzin Utz AG
32% Upside
SXT
Sensient Technologies Corp
12% Upside
C
688267
China Catalyst Holding Co Ltd
24% Upside
NEOGEN
Neogen Chemicals Ltd
18% Upside
603260
Hoshine Silicon Industry Co Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
PCC Rokita SA

For the last 8 years the compound annual growth rate for PCC Rokita SA's revenue is 11%. The projected CAGR for the next 3 years is -2%.

11%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
PCC Rokita SA

For the last 8 years the compound annual growth rate for PCC Rokita SA's operating income is 17%. The projected CAGR for the next 3 years is -11%.

17%
Past Growth
-11%
Estimated Growth
Estimates Accuracy
9%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
PCC Rokita SA

For the last 8 years the compound annual growth rate for PCC Rokita SA's net income is 15%. The projected CAGR for the next 3 years is -12%.

15%
Past Growth
-12%
Estimated Growth
Estimates Accuracy
17%
Average Beat
What are analyst estimates?

See Also

Summary
PCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
PCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PCR stock valuation using valuation multiples.
Wall Street Estimates
PCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PCR's stock price target?
Price Target
86.68 PLN

According to Wall Street analysts, the average 1-year price target for PCR is 86.68 PLN with a low forecast of 83.4 PLN and a high forecast of 91.77 PLN.

What is PCC Rokita SA's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for PCC Rokita SA's revenue is 11%. The projected CAGR for the next 3 years is -2%.

What is PCC Rokita SA's Operating Income forecast?
Projected CAGR
-11%

For the last 8 years the compound annual growth rate for PCC Rokita SA's operating income is 17%. The projected CAGR for the next 3 years is -11%.

What is PCC Rokita SA's Net Income forecast?
Projected CAGR
-12%

For the last 8 years the compound annual growth rate for PCC Rokita SA's net income is 15%. The projected CAGR for the next 3 years is -12%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 201,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.